The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of exposure misclassification in spontaneous ADR reports on the time to detection of product-specific risks for biologicals: a simulation study

Published:2015-12-16 Issue:3 Volume:25 Page:297-306
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Vermeer Niels S.¹²,Ebbers Hans C.¹,Straus Sabine M. J. M.²³,Leufkens Hubert G. M.¹²,Egberts Toine C. G.¹⁴,De Bruin Marie L.¹²

Affiliation:

1. Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmacoepidemiology and Clinical Pharmacology; Utrecht University; Utrecht The Netherlands

2. Medicines Evaluation Board; Utrecht The Netherlands

3. Medical Informatics, Erasmus Medical Center; Rotterdam The Netherlands

4. Department of Clinical Pharmacy; University Medical Center Utrecht; Utrecht The Netherlands

Funder

College ter Beoordeling van Geneesmiddelen

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3929/fullpdf

Reference43 articles.

1. Differential misclassification arising from nondifferential errors in exposure measurement;Flegal;Am J Epidemiol,1991

2. A study of the effects of exposure misclassification due to the time-window design in pharmacoepidemiologic studies;Staa;J Clin Epidemiol,1994

3. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI);Ilkhanoff;Pharmacoepidemiol Drug Saf,2005

4. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project;Carson;Blood,2009

5. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials;Bongartz;JAMA,2006

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance System in EU;Pharmacovigilance Essentials;2024

2. Identifiability of Biologicals: An Analysis Using EudraVigilance, the European Union's Database of Reports of Suspected Adverse Drug Reactions;Clinical Pharmacology & Therapeutics;2021-09-26

3. The Automatic Substitution of Biosimilars: Definitions of Interchangeability are not Interchangeable;Advances in Therapy;2021-03-21

4. Pharmacovigilance of Innovator Biologics and Biosimilars;Biologics, Biosimilars, and Biobetters;2020-12-30

5. FDA Biosimilar Action Plan: could improving pharmacovigilance of biologics improve patient and physician confidence in biosimilars?;Expert Opinion on Drug Safety;2020-03-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3